Ad
BLRX Short Information BioLineRx Ltd.
home / stock / blrx / blrx short
Short Information | BioLineRx Ltd. (NASDAQ:BLRX)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 75,422,118 |
| Total Actual Volume | 375,904,737 |
| Short Trends | |
|---|---|
| Cover Days | 19 |
| Short Days | 0 |
| No Change Days | 1 |
| Averages | |
|---|---|
| Average Short Volume | 3,771,106 |
| Average Short Percentage | 22.69% |
Is there a BLRX Short Squeeze or Breakout about to happen?
See the BLRX Short Analysis for free Sign up or Login
Powered by Squeeze Report
BLRX Twenty Trading Day's Volume to Short Volume Chart
BLRX Twenty Trading Day Price Chart
BLRX Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-17-2025 | $0.0979 | $0.1015 | $0.1064 | $0.0815 | 25,556,989 | 6,120,048 | 23.95% |
| 01-16-2025 | $0.0996 | $0.1219 | $0.135 | $0.099 | 107,571,344 | 23,558,055 | 21.9% |
| 01-15-2025 | $0.12 | $0.1046 | $0.1234 | $0.1025 | 11,241,927 | 3,111,684 | 27.68% |
| 01-14-2025 | $0.1342 | $0.123 | $0.1342 | $0.1153 | 11,284,836 | 2,342,786 | 20.76% |
| 01-13-2025 | $0.15 | $0.1374 | $0.15 | $0.1256 | 8,692,103 | 1,281,980 | 14.75% |
| 01-10-2025 | $0.1389 | $0.1429 | $0.144 | $0.1353 | 8,778,252 | 1,282,601 | 14.61% |
| 01-08-2025 | $0.162 | $0.1426 | $0.162 | $0.1352 | 15,129,283 | 2,784,966 | 18.41% |
| 01-07-2025 | $0.162 | $0.16 | $0.1625 | $0.148 | 19,086,306 | 1,697,074 | 8.89% |
| 01-06-2025 | $0.1873 | $0.1619 | $0.19 | $0.15 | 44,739,671 | 8,473,413 | 18.94% |
| 01-03-2025 | $0.3 | $0.2738 | $0.31 | $0.26 | 77,306,023 | 10,541,086 | 13.64% |
| 01-02-2025 | $0.225 | $0.2556 | $0.3674 | $0.2201 | 34,479,610 | 11,075,221 | 32.12% |
| 12-31-2024 | $0.21 | $0.214 | $0.22 | $0.2032 | 1,393,415 | 414,338 | 29.74% |
| 12-30-2024 | $0.2187 | $0.2115 | $0.2255 | $0.201 | 1,538,273 | 315,438 | 20.51% |
| 12-27-2024 | $0.228 | $0.2216 | $0.234 | $0.2063 | 1,365,021 | 265,313 | 19.44% |
| 12-26-2024 | $0.25 | $0.2241 | $0.2568 | $0.218 | 2,142,741 | 618,403 | 28.86% |
| 12-24-2024 | $0.222 | $0.2334 | $0.2342 | $0.222 | 855,695 | 215,880 | 25.23% |
| 12-23-2024 | $0.2175 | $0.2228 | $0.2228 | $0.205 | 1,746,584 | 477,919 | 27.36% |
| 12-20-2024 | $0.205 | $0.203 | $0.208 | $0.197 | 921,549 | 198,476 | 21.54% |
| 12-19-2024 | $0.192 | $0.202 | $0.209 | $0.19 | 608,715 | 222,864 | 36.61% |
| 12-18-2024 | $0.21 | $0.1952 | $0.211 | $0.187 | 1,466,400 | 424,573 | 28.95% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
BioLineRx Announces $10 Million Registered Direct Offering PR Newswire TEL AVIV, Israel , Jan. 6, 2025 /PRNewswire/ -- BioLineRx Ltd. (Nasdaq: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a development stage biopharmaceutical company pursuing life-chan...
-
BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value PR Newswire - Executed license agreement with Ayrmid Ltd. for APHEXDA ® (motixafortide) for $10 million upfront, up to $87 millio...
-
Waitr Holdings Inc. (ASAPQ) is expected to report for Q3 2024 Gold Reserve Ltd Ord (GDRZF) is expected to report for Q3 2024 Alarum Technologies Ltd. (ALAR) is expected to report for Q3 2024 Central Garden & Pet Company (CENT) is expected to report $-0.2 for Q4 2024 Fluence En...